Conklin Company, Inc. – FDA EIR, May 23, 2012

An FDA surveillance inspection of Conklin Company, Inc., located at 551 Valley Park Dr., Shakopee, MN, was conducted on May 23, 2012. The primary objective was to evaluate the firm's adherence to federal regulations 21 CFR 589.2000/589.2001, which pertain to preventing prohibited materials in animal feed, particularly concerning Bovine Spongiform Encephalopathy (BSE).Conklin Company functions as a distributor and retailer of microbial supplements for pets and livestock. They do not manufacture, process, or package feed on-site; all feed products are pre-packaged and sourced from external toll-milling firms. A significant portion of their feed products are distributed outside Minnesota, with additional exports to Canada and Japan.The inspection found no objectionable conditions or deviations from the specified regulatory framework. As a result, no FDA Form 483, 'Inspectional Observations,' was issued, indicating the company was in full compliance with the regulations at the time of the inspection. No samples were collected, and no regulatory actions were required.